BATRA vs IAC

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong year-over-year earnings growth and solid operating margins, the company is unprofitable on net (negative profit margin and ROE), carries a high debt/equity ratio of 1.52, and shows poor liquidity with current and quick ratios below 1.0. Valuation metrics are stretched, with a negative forward P/E and a Price/Book of 4.80, while insider activity is decisively bearish, with recent selling by major shareholders. The stock has underperformed recently, down 13.4% over six months, and lacks analyst coverage, increasing uncertainty.

IAC presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating deteriorating operational health, contrasted by a strong liquidity position and deep value valuation. While the company trades at a significant discount to book value (P/B 0.67), it is struggling with negative revenue growth (-10.5% YoY) and highly volatile earnings. The balance sheet remains healthy with low debt/equity (0.34) and a strong current ratio (2.75), providing a safety buffer despite operational headwinds. The overall outlook is neutral as the deep value is offset by shrinking top-line growth and poor fundamental health scores.